Intranasal Corticosteroids: A Personalized Medicine Approach

Tomer Boldes*, Benny Nageris, Firas Kassem, Ameen Biadsee

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Intranasal corticosteroids (INCS) are frequently prescribed for allergic rhinitis but can also be used for other indications, such as sinusitis and nasal congestion. INCS are considered effective in controlling nasal symptoms with a similar safety profile among the different INCS formulations. In this review, we presented all available INCS formulations marketed in Israel while emphasizing the differences among them with a practical approach for medical providers in selecting a specific INCS agent. We conducted a literature review using PubMed, Medline, and Google Scholar to identify articles related to INCS, triamcinolone acetonide, fluticasone propionate, and fluticasone furoate. Currently, five brands of INCS are available in Israel. While they all have similar efficacy in treating nasal symptoms, only fluticasone furoate consistently demonstrated a reduction in ocular symptoms compared to placebo. Other differences included sensory attributes, recommended regimens, approved age for use, and cost. When selecting INCS agent, a personalized approach is advised. Factors such as age, co-morbidities, concurrent medications, pregnancy, and patient preferences should be considered.

Original languageEnglish
Pages (from-to)324-332
Number of pages9
JournalIsrael Medical Association Journal
Volume26
Issue number5
StatePublished - May 2024

Keywords

  • Correspondence
  • allergic rhinitis
  • intranasal corticosteroids (INCS)
  • nasal congestion
  • nasal spray
  • patient preferences

Fingerprint

Dive into the research topics of 'Intranasal Corticosteroids: A Personalized Medicine Approach'. Together they form a unique fingerprint.

Cite this